Furthermore, the study revealed intra- and inter-tissue heterogeneity in CaSR expression, particularly within neoplastic tissues, and proposed that defects in CaSR trafficking from the cytoplasm to the cell surface might contribute to the reduced membranous expression observed in adenomas and carcinomas. This evidence concerns the gene CASR and carcinoma.